- Home
- ANIP vs HCI Comparison
ANIP vs HCI Comparison
Compare ANIP & HCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- HCI
- Stock Information
- Founded
- ANIP 2001
- HCI 2006
- Country
- ANIP United States
- HCI United States
- Employees
- ANIP N/A
- HCI N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- HCI Property-Casualty Insurers
- Sector
- ANIP Health Care
- HCI Finance
- Exchange
- ANIP Nasdaq
- HCI Nasdaq
- Market Cap
- ANIP 1.2B
- HCI 1.2B
- IPO Year
- ANIP N/A
- HCI N/A
- Fundamental
- Price
- ANIP $55.67
- HCI $111.32
- Analyst Decision
- ANIP Buy
- HCI Buy
- Analyst Count
- ANIP 7
- HCI 5
- Target Price
- ANIP $77.33
- HCI $140.00
- AVG Volume (30 Days)
- ANIP 253.7K
- HCI 127.6K
- Earning Date
- ANIP 11-08-2024
- HCI 11-07-2024
- Dividend Yield
- ANIP N/A
- HCI 1.42%
- EPS Growth
- ANIP N/A
- HCI 163.93
- EPS
- ANIP N/A
- HCI 11.94
- Revenue
- ANIP $555,456,000.00
- HCI $750,846,000.00
- Revenue This Year
- ANIP $25.49
- HCI N/A
- Revenue Next Year
- ANIP $19.92
- HCI $7.38
- P/E Ratio
- ANIP N/A
- HCI $9.45
- Revenue Growth
- ANIP 23.60
- HCI 48.73
- 52 Week Low
- ANIP $52.00
- HCI $81.35
- 52 Week High
- ANIP $70.81
- HCI $126.50
- Technical
- Relative Strength Index (RSI)
- ANIP 42.29
- HCI 47.83
- Support Level
- ANIP $55.29
- HCI $110.02
- Resistance Level
- ANIP $57.33
- HCI $116.18
- Average True Range (ATR)
- ANIP 1.88
- HCI 3.90
- MACD
- ANIP -0.16
- HCI -0.59
- Stochastic Oscillator
- ANIP 5.34
- HCI 20.39
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid dose products. Its areas of product development include narcotics, oncolytic, hormones and steroids, and complex formulations involving extended release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About HCI HCI Group Inc.
HCI Group Inc is engaged in the property and casualty insurance business through two Florida domiciled insurance companies, Homeowners Choice Property & Casualty Insurance Company (HCPCI) and TypTap Insurance Company (TypTap). Both HCPCI and TypTap are authorized to underwrite various homeowners' property and casualty insurance products and allied lines business in the state of Florida and other states. The operating segments of the group are HCPCI insurance operations, TypTap Group, Real estate operations, and Corporate and other. It derives key revenue from the HCPCI Insurance operation segment.